These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38468477)

  • 1. The economic burden of systemic lupus erythematosus in Mexico.
    Elsisi GH; Andrade-Ortega L; Portela M; Ramírez GM
    J Med Econ; 2024; 27(sup1):12-22. PubMed ID: 38468477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of systemic lupus erythematosus in United Arab Emirates.
    Alansari A; Hannawi S; Aldhaheri A; Zamani N; Elsisi GH; Aldalal S; Naeem WA; Farghaly M
    J Med Econ; 2024; 27(sup1):35-45. PubMed ID: 38468482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic burden of systemic lupus erythematosus in Colombia.
    Elsisi GH; Quintana G; Gil D; Santos P; Fernandez D
    J Med Econ; 2024; 27(sup1):1-11. PubMed ID: 38468478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of systemic lupus erythematosus in Malaysia.
    Elsisi GH; Joe AY; Zain MM; Yusoof HM; Teh CL; Mohd AB; Khor XT; Isa LBM
    J Med Econ; 2024; 27(sup1):46-55. PubMed ID: 38468479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of systemic lupus erythematosus in Taiwan.
    Elsisi GH; Hsieh SC; Chen DY
    J Med Econ; 2024; 27(sup1):56-66. PubMed ID: 38468480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
    Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T
    Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States.
    Kariburyo F; Xie L; Sah J; Li N; Lofland JH
    J Med Econ; 2020 Jan; 23(1):1-9. PubMed ID: 31589081
    [No Abstract]   [Full Text] [Related]  

  • 8. Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico.
    Añorve Bailon D; Picó-Guzmán J; Cifuentes S; Trejo R; Rodríguez Cid J; Juarez-Vignon Whaley JJ; Heredia Zepeda AA; Gerson R; Camacho-Limas CP; Martínez-Herrera JF; Molina DB; Camarín Sánchez E; Shveid Gerson D
    Pharmacoecon Open; 2024 Nov; 8(6):869-885. PubMed ID: 39107537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
    Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
    J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic characterization of mild, moderate, and severe systemic lupus erythematosus: Real-world observation across payer channels in the United States.
    Wu SS; Perry A; Tkacz J; Bryant G
    J Manag Care Spec Pharm; 2023 Sep; 29(9):1010-1020. PubMed ID: 37610115
    [No Abstract]   [Full Text] [Related]  

  • 11. An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States.
    Bell CF; Ajmera MR; Meyers J
    Lupus; 2022 Feb; 31(2):202-211. PubMed ID: 35060407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus.
    Lokhandwala T; Coutinho AD; Bell CF
    Clin Ther; 2021 Aug; 43(8):1320-1335. PubMed ID: 34243966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study.
    He X; Lloyd E; Cooper S; Li L; Chauhan D; Juliao P; Quasny H; Bao C
    Value Health Reg Issues; 2023 Sep; 37():88-96. PubMed ID: 37379801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study.
    Miyazaki C; Sruamsiri R; Mahlich J; Jung W
    J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004-2015.
    Hammond ER; Desta B; Near AM; Wang X; Jiang M
    Lupus Sci Med; 2021 Sep; 8(1):. PubMed ID: 34556546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare utilization and costs of systemic lupus erythematosus in Medicaid.
    Kan HJ; Song X; Johnson BH; Bechtel B; O'Sullivan D; Molta CT
    Biomed Res Int; 2013; 2013():808391. PubMed ID: 23484162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The humanistic and economic burden of systemic lupus erythematosus : a systematic review.
    Meacock R; Dale N; Harrison MJ
    Pharmacoeconomics; 2013 Jan; 31(1):49-61. PubMed ID: 23329592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
    Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
    Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States.
    Bell CF; Huang SP; Cyhaniuk A; Averell CM
    Lupus; 2023 Feb; 32(2):301-309. PubMed ID: 36542670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
    Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
    Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.